ピーナッツアレルギー治療の世界市場レポート 2025年

ピーナッツアレルギー治療の市場規模は今後数年で急成長が見込まれます。2029年にはCAGR11.1％で7億7,000万米ドルに成長します。予測期間の成長は、継続的な有病率の上昇、個別化医療アプローチの拡大、新規免疫療法治療の導入、官民投資の拡大、遠隔医療サービスの拡大に起因すると考えられます。予測期間における主な動向には、免疫療法の採用拡大、生物学的療法の進歩、プロバイオティクスに基づく治療の統合、送達システムの技術革新、個別化医療アプローチ、規制当局の承認と支援が含まれます。

アレルギー治療のための研究開発投資は、ピーナッツアレルギー治療市場の成長を促進します。研究開発（R&D）投資は、技術革新と製品開発に向けた財源を伴うもので、ピーナッツアレルギーの治療法を進歩させるために極めて重要です。こうした投資は、アレルギー反応を軽減し、ピーナッツアレルギー患者の生活の質を高めることを目的とした、革新的な免疫療法や減感作技術の創出を促進します。例えば、ビクトリア州政府は2024年1月、世界のピーナッツアレルギー治療を推進するため、オーストラリアを拠点とするバイオテクノロジー企業であるアラバックス社に1,200万米ドルの戦略的投資を行うことを発表しました。この資金は6,600万米ドル規模の構想の一部で、アラバックスの革新的な免疫療法PVX108の開発を支援するもので、米国FDAとオーストラリアTGAから第2相臨床試験の承認を得ており、世界の公衆衛生に影響を与える可能性を強調しています。このように、アレルギー治療への研究開発投資がピーナッツアレルギー治療市場の成長を後押ししています。

ピーナッツアレルギー治療市場の主なプレーヤーは、ピーナッツアレルギーを管理し、患者の転帰を改善するために、より的を絞った効果的なソリューションを提供するために、抗IgEモノクローナル抗体などの生物学的療法の開発を優先しています。これらの抗体は、体内の免疫グロブリンE（IgE）抗体を標的として中和するように設計されています。例えば、2024年2月、ノバルティス・ファーマシューティカルズ株式会社は、IgEを介する食物アレルギー患者におけるアナフィラキシーを含むアレルギー反応の軽減を目的としたゾレア（オマリズマブ）のFDA承認を取得しました。この承認は、NIH主催の第III相OUtMATCH試験のデータに基づくもので、プラセボ投与群と比較して、Xolair投与群では食物アレルギー耐容能が有意に改善することが強調されています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界ピーナッツアレルギー治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のピーナッツアレルギー治療市場：成長率分析
• 世界のピーナッツアレルギー治療市場の実績：規模と成長, 2019-2024
• 世界のピーナッツアレルギー治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界ピーナッツアレルギー治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のピーナッツアレルギー治療市場薬剤クラス別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗ヒスタミン薬
• 免疫療法
• エピネフリン
• その他の薬物クラス
• 世界のピーナッツアレルギー治療市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 注射剤
• オーラル
• その他の投与経路
• 世界のピーナッツアレルギー治療市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 小売薬局
• 病院薬局
• その他の流通チャネル
• 世界のピーナッツアレルギー治療市場抗ヒスタミン薬の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口抗ヒスタミン薬
• 局所抗ヒスタミン薬
• 世界のピーナッツアレルギー治療市場免疫療法の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口免疫療法（OIT）
• 舌下免疫療法（SLIT）
• 皮膚上免疫療法（EPIT）
• 世界のピーナッツアレルギー治療市場エピネフリンの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• エピネフリン自己注射器
• エピネフリン吸入器
• 世界のピーナッツアレルギー治療市場、その他の薬物クラスのタイプ別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ロイコトリエン受容体拮抗薬
• モノクローナル抗体
• コルチコステロイド

第7章 地域別・国別分析

• 世界のピーナッツアレルギー治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のピーナッツアレルギー治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ピーナッツアレルギー治療市場：競合情勢
• ピーナッツアレルギー治療市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Viatris Inc.
• Regeneron Pharmaceuticals Inc.
• Hikma Pharmaceuticals plc
• ALK-Abello A/S
• Amneal Pharmaceuticals Inc.
• Amphastar Pharmaceuticals Inc.
• Stallergenes Greer plc
• kaleo Inc.
• Aquestive Therapeutics Inc.
• Vedanta Biosciences Inc.
• Aimmune Therapeutics Inc.
• AnaptysBio Inc.
• Alladapt Immunotherapeutics Inc.
• Aravax Pty Ltd
• Intrommune Therapeutics Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• ピーナッツアレルギー治療市場2029：新たな機会を提供する国
• ピーナッツアレルギー治療市場2029：新たな機会を提供するセグメント
• ピーナッツアレルギー治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Peanut allergy treatment encompasses various medical approaches aimed at managing and reducing the severity of allergic reactions to peanuts. These treatments include strategies such as epicutaneous immunotherapy and biologic therapies, which are intended to desensitize individuals to peanuts and alleviate allergic reactions.

The main drug classes used in peanut allergy treatment include antihistamines, immunotherapies, epinephrine, and others. Antihistamines are medications that relieve allergy symptoms by blocking the action of histamine, a substance released by the immune system during allergic reactions. These drugs can be administered through injectables, orally, and by other methods. They are typically distributed through retail pharmacies, hospital pharmacies, and other healthcare facilities.

The peanut allergy treatment research report is one of a series of new reports from The Business Research Company that provides peanut allergy treatment market statistics, including the peanut allergy treatment industry's global market size, regional shares, competitors with a peanut allergy treatment market share, detailed peanut allergy treatment market segments, market trends and opportunities, and any further data you may need to thrive in the peanut allergy treatment industry. This peanut allergy treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The peanut allergy treatment market size has grown rapidly in recent years. It will grow from $0.45 billion in 2024 to $0.51 billion in 2025 at a compound annual growth rate (CAGR) of 11.4%. The growth in the historic period can be attributed to increased prevalence, advancements in diagnostic testing, growing public awareness and concern, development of early intervention strategies, and regulatory approvals for peanut allergy treatments.

The peanut allergy treatment market size is expected to see rapid growth in the next few years. It will grow to $0.77 billion in 2029 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to a continued rise in the prevalence, expansion of personalized medicine approaches, the introduction of novel immunotherapy treatments, growth in public and private investment, and expansion of telemedicine services. Major trends in the forecast period include the increased adoption of immunotherapy, advancements in biologic therapies, integration of probiotic-based treatments, technological innovations in delivery systems, personalized medicine approaches, and regulatory approvals and support.

Investments in research and development for allergy treatments are poised to propel the growth of the peanut allergy treatment market. Research and development (R&D) investments, involving financial resources directed toward innovation and product development, are crucial for advancing therapies for peanut allergies. These investments drive the creation of innovative immunotherapies and desensitization techniques aimed at reducing allergic reactions and enhancing the quality of life for individuals affected by peanut allergies. For instance, in January 2024, the Victorian Government announced a strategic $12 million investment in Aravax, an Australia-based biotechnology company, to advance global peanut allergy treatment. This funding, part of a broader $66 million initiative, supports the development of Aravax's innovative immunotherapy, PVX108, with Phase 2 trial approvals from the U.S. FDA and Australia's TGA highlighting its potential impact on public health worldwide. Thus, research and development investments in allergy treatments are fueling the growth of the peanut allergy treatment market.

Key players in the peanut allergy treatment market are prioritizing the development of biologic therapies, such as anti-IgE monoclonal antibodies, to offer more targeted and effective solutions for managing peanut allergies and improving patient outcomes. These antibodies are designed to target and neutralize immunoglobulin E (IgE) antibodies in the body. For example, in February 2024, Novartis Pharmaceuticals Corporation received FDA approval for Xolair (omalizumab), intended to reduce allergic reactions, including anaphylaxis, in patients with IgE-mediated food allergies. The approval, based on data from the NIH-sponsored Phase III OUtMATCH study, underscores significant improvement in food allergy tolerance among patients treated with Xolair compared to those receiving a placebo.

In September 2023, Stallergenes Greer International AG acquired the peanut allergy drug Palforzia from Nestle S.A. for an undisclosed amount. This acquisition expands Stallergenes Greer's anti-allergy portfolio, complementing its suite of approved products targeting various allergies. Nestle S.A., a provider of food, beverage, and pharmaceutical products, had developed Palforzia for peanut allergy treatment.

Major companies operating in the peanut allergy treatment market are Pfizer Inc., F. Hoffmann-La Roche AG, Sanofi SA, Novartis AG, Takeda Pharmaceutical Company Limited, Viatris Inc., Regeneron Pharmaceuticals Inc., Hikma Pharmaceuticals plc, ALK-Abello A/S, Amneal Pharmaceuticals Inc., Amphastar Pharmaceuticals Inc, Stallergenes Greer plc, kaleo Inc., Aquestive Therapeutics Inc., Vedanta Biosciences Inc., Aimmune Therapeutics Inc., AnaptysBio Inc., Alladapt Immunotherapeutics Inc., Aravax Pty Ltd, Intrommune Therapeutics Inc., IgGenix Inc., DBV Technologies SA, Camallergy Ltd., HAL Allergy Group, Prota Therapeutics Pty Ltd.

North America was the largest region in the peanut allergy treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peanut allergy treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the peanut allergy treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The peanut allergy treatment market consists of revenues earned by entities by providing services such as diagnostic testing, personalized treatment plans, oral immunotherapy sessions, patient education and counseling, monitoring of allergic reactions, and access to emergency care. The market value includes the value of related goods sold by the service provider or included within the service offering. The peanut allergy treatment market also includes sales of allergy drops, allergy tablets, and peanut allergen extract. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Peanut Allergy Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on peanut allergy treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for peanut allergy treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The peanut allergy treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Class: Antihistamines; Immunotherapies; Epinephrine; Other Drug Classes
• 2) By Route Of Administration: Injectable; Oral; Other Routes Of Administration
• 3) By Distribution Channel: Retail Pharmacy; Hospital Pharmacy; Other Distribution Channels
• Subsegments:
• 1) By Antihistamines: Oral Antihistamines; Topical Antihistamines
• 2) By Immunotherapies: Oral Immunotherapy (OIT); Sublingual Immunotherapy (SLIT); Epicutaneous Immunotherapy (EPIT)
• 3) By Epinephrine: Epinephrine Auto-Injectors; Epinephrine Inhalers
• 4) By Other Drug Classes: Leukotriene Receptor Antagonists; Monoclonal Antibodies; Corticosteroids
• Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche AG; Sanofi SA; Novartis AG; Takeda Pharmaceutical Company Limited
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Peanut Allergy Treatment Market Characteristics

3. Peanut Allergy Treatment Market Trends And Strategies

4. Peanut Allergy Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Peanut Allergy Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Peanut Allergy Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Peanut Allergy Treatment Market Growth Rate Analysis
• 5.4. Global Peanut Allergy Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Peanut Allergy Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Peanut Allergy Treatment Total Addressable Market (TAM)

6. Peanut Allergy Treatment Market Segmentation

• 6.1. Global Peanut Allergy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antihistamines
• Immunotherapies
• Epinephrine
• Other Drug Classes
• 6.2. Global Peanut Allergy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injectable
• Oral
• Other Routes Of Administration
• 6.3. Global Peanut Allergy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Retail Pharmacy
• Hospital Pharmacy
• Other Distribution Channels
• 6.4. Global Peanut Allergy Treatment Market, Sub-Segmentation Of Antihistamines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Antihistamines
• Topical Antihistamines
• 6.5. Global Peanut Allergy Treatment Market, Sub-Segmentation Of Immunotherapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Immunotherapy (OIT)
• Sublingual Immunotherapy (SLIT)
• Epicutaneous Immunotherapy (EPIT)
• 6.6. Global Peanut Allergy Treatment Market, Sub-Segmentation Of Epinephrine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Epinephrine Auto-Injectors
• Epinephrine Inhalers
• 6.7. Global Peanut Allergy Treatment Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Leukotriene Receptor Antagonists
• Monoclonal Antibodies
• Corticosteroids

7. Peanut Allergy Treatment Market Regional And Country Analysis

• 7.1. Global Peanut Allergy Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Peanut Allergy Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Peanut Allergy Treatment Market

• 8.1. Asia-Pacific Peanut Allergy Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Peanut Allergy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Peanut Allergy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Peanut Allergy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Peanut Allergy Treatment Market

• 9.1. China Peanut Allergy Treatment Market Overview
• 9.2. China Peanut Allergy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Peanut Allergy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Peanut Allergy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Peanut Allergy Treatment Market

• 10.1. India Peanut Allergy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Peanut Allergy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Peanut Allergy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Peanut Allergy Treatment Market

• 11.1. Japan Peanut Allergy Treatment Market Overview
• 11.2. Japan Peanut Allergy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Peanut Allergy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Peanut Allergy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Peanut Allergy Treatment Market

• 12.1. Australia Peanut Allergy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Peanut Allergy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Peanut Allergy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Peanut Allergy Treatment Market

• 13.1. Indonesia Peanut Allergy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Peanut Allergy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Peanut Allergy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Peanut Allergy Treatment Market

• 14.1. South Korea Peanut Allergy Treatment Market Overview
• 14.2. South Korea Peanut Allergy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Peanut Allergy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Peanut Allergy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Peanut Allergy Treatment Market

• 15.1. Western Europe Peanut Allergy Treatment Market Overview
• 15.2. Western Europe Peanut Allergy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Peanut Allergy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Peanut Allergy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Peanut Allergy Treatment Market

• 16.1. UK Peanut Allergy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Peanut Allergy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Peanut Allergy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Peanut Allergy Treatment Market

• 17.1. Germany Peanut Allergy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Peanut Allergy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Peanut Allergy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Peanut Allergy Treatment Market

• 18.1. France Peanut Allergy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Peanut Allergy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Peanut Allergy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Peanut Allergy Treatment Market

• 19.1. Italy Peanut Allergy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Peanut Allergy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Peanut Allergy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Peanut Allergy Treatment Market

• 20.1. Spain Peanut Allergy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Peanut Allergy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Peanut Allergy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Peanut Allergy Treatment Market

• 21.1. Eastern Europe Peanut Allergy Treatment Market Overview
• 21.2. Eastern Europe Peanut Allergy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Peanut Allergy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Peanut Allergy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Peanut Allergy Treatment Market

• 22.1. Russia Peanut Allergy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Peanut Allergy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Peanut Allergy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Peanut Allergy Treatment Market

• 23.1. North America Peanut Allergy Treatment Market Overview
• 23.2. North America Peanut Allergy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Peanut Allergy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Peanut Allergy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Peanut Allergy Treatment Market

• 24.1. USA Peanut Allergy Treatment Market Overview
• 24.2. USA Peanut Allergy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Peanut Allergy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Peanut Allergy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Peanut Allergy Treatment Market

• 25.1. Canada Peanut Allergy Treatment Market Overview
• 25.2. Canada Peanut Allergy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Peanut Allergy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Peanut Allergy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Peanut Allergy Treatment Market

• 26.1. South America Peanut Allergy Treatment Market Overview
• 26.2. South America Peanut Allergy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Peanut Allergy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Peanut Allergy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Peanut Allergy Treatment Market

• 27.1. Brazil Peanut Allergy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Peanut Allergy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Peanut Allergy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Peanut Allergy Treatment Market

• 28.1. Middle East Peanut Allergy Treatment Market Overview
• 28.2. Middle East Peanut Allergy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Peanut Allergy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Peanut Allergy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Peanut Allergy Treatment Market

• 29.1. Africa Peanut Allergy Treatment Market Overview
• 29.2. Africa Peanut Allergy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Peanut Allergy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Peanut Allergy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Peanut Allergy Treatment Market Competitive Landscape And Company Profiles

• 30.1. Peanut Allergy Treatment Market Competitive Landscape
• 30.2. Peanut Allergy Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis

31. Peanut Allergy Treatment Market Other Major And Innovative Companies

• 31.1. Viatris Inc.
• 31.2. Regeneron Pharmaceuticals Inc.
• 31.3. Hikma Pharmaceuticals plc
• 31.4. ALK-Abello A/S
• 31.5. Amneal Pharmaceuticals Inc.
• 31.6. Amphastar Pharmaceuticals Inc.
• 31.7. Stallergenes Greer plc
• 31.8. kaleo Inc.
• 31.9. Aquestive Therapeutics Inc.
• 31.10. Vedanta Biosciences Inc.
• 31.11. Aimmune Therapeutics Inc.
• 31.12. AnaptysBio Inc.
• 31.13. Alladapt Immunotherapeutics Inc.
• 31.14. Aravax Pty Ltd
• 31.15. Intrommune Therapeutics Inc.

32. Global Peanut Allergy Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Peanut Allergy Treatment Market

34. Recent Developments In The Peanut Allergy Treatment Market

35. Peanut Allergy Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Peanut Allergy Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Peanut Allergy Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Peanut Allergy Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer